by Xia & He Publishing Inc. Credit: Journal of Clinical and Translational Hepatology (2024). DOI: 10.14218/JCTH.2023.00207 Nonalcoholic fatty liver disease (NAFLD), now reclassified as metabolic dysfunction-associated steatotic liver disease (MASLD), and its more severe form, nonalcoholic steatohepatitis (NASH), renamed metabolic dysfunction-associated steatohepatitis (MASH), are increasingly recognized as major contributors to chronic liver disease (CLD) and...
Tag: <span>steatohepatitis</span>
Post
Aldo-keto reductase family 1 member B10 predicts advanced nonalcoholic steatohepatitis
KANAZAWA UNIVERSITY [Background] Nonalcoholic steatohepatitis (NASH) is associated with liver inflammation in patients with nonalcoholic fatty liver disease (NAFLD), and it can progress to liver fibrosis at an advanced stage, and also to hepatocellular carcinoma (HCC) and portal hypertension. Although liver fibrosis is considered to be accurately diagnosed via biopsy, noninvasive methods are preferable. Aldo-keto...